Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
243.75
+0.31 (+0.13%)
Streaming Delayed Price
Updated: 2:01 PM EST, Feb 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,611,795
Open
244.13
Bid (Size)
243.73 (300)
Ask (Size)
243.79 (100)
Prev. Close
243.45
Today's Range
241.87 - 244.49
52wk Range
141.50 - 246.35
Shares Outstanding
2,628,679,824
Dividend Yield
2.13%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Behind the Scenes of Johnson & Johnson's Latest Options Trends
↗
Today 12:00 EST
Via
Benzinga
Johnson & Johnson's New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner
↗
Today 11:45 EST
FDA approves monthly dosing for J&J's Rybrevant Faspro with Lazcluze, offering faster, easier treatment for EGFR lung cancer.
Via
Benzinga
Performance
YTD
+17.6%
+17.6%
1 Month
+11.7%
+11.7%
3 Month
+22.1%
+22.1%
6 Month
+38.3%
+38.3%
1 Year
+57.3%
+57.3%
More News
Read More
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
Today 8:30 EST
From
BioMedWire
Via
GlobeNewswire
Johnson & Johnson (NYSE:JNJ) Stands Out as a High-Quality Dividend Aristocrat for Income Investors
↗
February 07, 2026
Via
Chartmill
The Seven-Thousand Siege: S&P 500’s Historic Breach and the Great Tech Pivot of 2026
February 16, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Earnings
ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
February 16, 2026
Via
MarketMinute
Topics
Intellectual Property
Jury: Johnson & Johnson Liabile in Case Linking Baby Powder to Cancer
↗
February 14, 2026
Via
Benzinga
Philadelphia Jury Returns $250,000 Verdict Against J&J in Latest Baby Powder-Ovarian Cancer Trial
February 13, 2026
From
Beasley Allen Law Firm
Via
Business Wire
Volatility Returns to Wall Street: VIX Surges 18% as AI Fatigue Triggers Massive Three-Day Sector Rotation
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
"Blowout" Jobs Report Ignites 2026 Growth Hopes as Unemployment Hits 4.3% Floor
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Workforce
The Great Rebound: US M&A Market Ignites as Megadeals Surge 111% in AI-Driven Supercycle
February 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Energy
Is Johnson & Johnson a Buy, Sell, or Hold in 2026?
↗
February 10, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
Lawsuit
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
February 10, 2026
Via
FinancialNewsMedia
Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference
February 09, 2026
From
Johnson & Johnson
Via
Business Wire
5 Stocks and ETFs to Help Shield Your Portfolio During Volatility
↗
February 09, 2026
Via
MarketBeat
Topics
ETFs
Johnson & Johnson Reports 90% AFib Freedom In Early Heart Device Study
↗
February 09, 2026
Via
Benzinga
What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.
↗
February 08, 2026
Via
The Motley Fool
Topics
Bonds
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium
February 06, 2026
From
Johnson & Johnson
Via
Business Wire
Eli Lilly Booms, Then Busts: Stellar Guidance vs Hims Undercut
↗
February 06, 2026
Via
MarketBeat
Johnson & Johnson Is A Resilient Blue-Chip Stock And It Just Hit New All-Time Highs
↗
February 06, 2026
Via
Talk Markets
Johnson & Johnson Is a Resilient Blue-Chip Stock and It Just Hit New All-Time Highs
February 06, 2026
Via
Barchart.com
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
February 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Roivant Sciences (ROIV): Anatomy of a 15% Surge and the Future of the ‘Vant’ Model
February 06, 2026
Via
Finterra
Topics
ETFs
Economy
Initial Public Offering
The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition
February 05, 2026
Via
MarketMinute
Topics
Supply Chain
Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)
February 05, 2026
Via
Finterra
Topics
Product Recall
World Trade
Frequently Asked Questions
Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 243.75
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 02/17/26 02:01 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 640.75B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 641B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.